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Purpose: This study was undertaken to examine the effectiveness and the possible advan- 
tages of infrainguinal arterial reconstruction with noureversed greater saphenous vein 
(NRGSV) grafts. We reviewed the results achieved with 189 consecutive NRGSV bypass 
procedures from July 1, 1985, to August 31, 1995, and compared them with 568 
consecutive in situ greater saphenous vein (INGSV) bypass procedures completed over the 
same interval. 
Methods: NRGSV bypass procedures were performed by selecting the optimum inflow and 
outflow vessels and then excising the best available appropriate-length segment of greater 
saphenous vein. The valves were lysed with a Mills valvulotome using gentle antegrade 
distention with an isotonic electrolyte solution containing heparin (1000 U/500 ml) and 
papaverine (60 rag/500 ml). The graft was then translocated tothe inflow site, where the 
proximal and distal anastomoses were sequentially completed, followed by a completion 
arteriography. 
Results: Demographic and risk factor characteristics did not differ between patients who 
underwent NRGSV and those who underwent INGSV bypass. Compared with INGSV 
bypasses, NRGSV bypasses were more commonly secondary procedures (26% vs 8%; p < 
0.001) and were more often performed for limb salvage indications (89% vs 68%; p < 
0.001). NRGSV bypasses also had more distal inflow vessels (23% superfidal femoral 
artery [SFA] and 28% popliteal artery [POP] vs 10% SFA and 1% POP; p < 0.001) and 
more distal outflow vessels (52% tibial and 22% pedal artery vs 47% tibial and 3% pedal 
artery; p < 0.001) than did INGSV bypasses. Despite the higher incidence of secondary 
bypass procedures and more distal outflow vessels in the NRGSV group, the overall 
results achieved at 5 years did not differ between the two groups. The 5-year primary 
patency rates were 65% - 5% for NRGSV and 72% -+ 3% for INGSV (p < 0.12), and the 
5-year secondary patency rates were 74% - 5% and 82% 4- 2% (p < 0.08), respectively. 
Similarly, the 5-year limb salvage rate among bypass procedures performed for limb 
salvage indications did not differ for NRGSV (82% - 5%) and INGSV (90% --- 2%; p < 
0.06). 
Conclusions: The application of the NRGSV bypass graft preserves the INGSV's main 
advantage of optimal size match between artery and vein at each anastomosis, but 
facilitates the tailoring of the procedure to the patients anatomy and the completion of the 
bypass with the shortest, best-quality conduit available. Our application of the NRGSV in 
a more challenging series of bypass procedures produced equivalent results to those 
achieved in a concurrent series of INGSV bypass procedures. (J Vase Surg 1996;24:957-62.) 
The in situ greater saphenous vein (GSV) is the 
conduit of  choice of  many vascular surgeons when 
performing infrainguinal arterial reconstruction. >4
When the ipsilateral GSV is not available or the 
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pathologic anatomy calls for an inflow site other than 
the proximal femoral artery, the GSV is generally 
used in the reversed configuration, s The theoretic 
advantages of the in situ GSV (INGSV), including a 
better size match between the artery and vein at the 
proximal and distal anastomosis and an increased vein 
usage rate, may be preserved in these situations, 
however, by using the GSV in a translocated, nonre- 
versed fashion with lysed valves (NRGSVL We ini- 
tially used this technique when the contralateral GSV 
was used for infrainguinal reconstrucnon, but have 
become increasingly liberal about its application as 
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Table I. Demographics and risk factors 
NRGSV INGSV p 
No. of patients 179 482 
No. of bypasses 189 568 
Mean age 66 67 <0.55 
No. operations in men (% 107 (57%) 320 (56%'~ <0.95 
No. operations inwomen (%) 82 43%~ 248 (44%) <0.95 
Diabetes mellitus (%) 100 (53%~ 232 (41%) <0.01 
Smoldng history 93 49% 280 (49%) <0.98 
Coronary artery disease 100 (53%~ 259,46%~ <0.08 
Prior CABG 23 12%~ 42,7%) <0.04 
Hypertension 121 64%] 342(60%) <0,35 
COPD 10 5%] 78 (14%) <0.01 
Renal failure 20 11%] 35 c6%) <0.04 
CABG, Coronary artery bypass graft; COPD, chronic obstructive 
pulmonary disease. 
we have attempted to optimally tailor the operative 
procedure to the patient's anatomy. Our general 
preference is to construct the shortest possible bypass 
conduit with the best quality GSV available. This 
often involves harvesting the GSV from the thigh and 
translocating it in a nonreversed configuration to a 
more distal inflow site, such as the superficial femoral 
or popliteal artery. This review was undertal~en to
evaluate our experience with this operative approach 
and to determine whether the results achieved with 
the NRGSV are comparable with those achieved with 
INGSV. 
PATIENTS AND METHODS 
From July 1, 1985, to August 31, 1995, a total of 
189 infrainguinal arterial reconstructions were per- 
formed in 179 patients with NRGSV. Composite 
vein grafts and nonreversed arln-vem grafts were 
excluded from the analysis. Over the same interval, 
568 reconstructions with INGSVs were completed in
482 panents. The demographic haracteristics for 
patients who underwent NRGSV reconstruction a d 
INGSV reconstruction are shown in Table I and were 
similar for the two groups. The mean follow-up in- 
terval was 31 months for INGSV grafts and 26 
months for NRGSV grafts. 
Indications. The NRGSV configuration was 
used at the discretion of the operating surgeon for a 
variety of indications. The most common indication 
was when a contralateral GSVwas required for a long 
bypass graft. The next mOSt common application 
involved procedures in which inflow sites other than 
the common femoral artery or proximal superficial 
femoral artery were used. In these procedures the 
GSV was translocated proximally onto the external 
iliac artery to avoid reoperating on a femoral artery or, 
more commonly, down onto the distal superficial 
femoral artery or popliteal artery to create the short- 
est bypass graft possible. Another common indication 
included procedures in which the graft was translo- 
cared to the subcutaneous position along the lateral 
thigh for bypass grafts to the proximal anterior tibial 
artery, or more rarely, to the distal peroneal artery. In 
some cases the GSV was translocated to a deeper 
anatomically tunneled plane in preference to the sub- 
cutaneous in sltu position. 
Surgical technique. The surgical technique for 
NRGSV and INGSV bypass procedures differed only 
in the preparation of the graft conduit. Our tech- 
nique for INGSV has been described previously. 2 
Salient points include a team approach consisting of a 
staff vascular surgeon and vascular fellow or  senior 
surgical resident. We prefer to expose the entire GSV 
from proximal to distal anastomosis. The proximal 
saphenous valve is excised under direct vision, and 
subsequent valve lysis is performed with the modified 
Mills valvulotome introduced through serial side 
branches as vein graft distention is maintained by 
pulsatile perfusion from above. Loupe magnification, 
completion arteriographic s ans, and standard anas- 
tomotic techniques were routinely used. Angioscopy 
was selectively used in a minority of cases (<5%). 
When the NRGSV is used, the GSV is gently 
harvested from its bed as side branches are ligated 
with 4-0 silk ties. To minimize the vein graft ischemic 
tame, the GSV is not removed and prepared until the 
proximal and distal arterial exposures have been com- 
pleted. Frequent irrigation is used to prevent vein 
graft dessication. The GSV is harvested flush with the 
common femoral vein to preserve the large proximal 
hood, which facilitates the completion of the proxi- 
mal anastomosis. The proximal valve is directly ex- 
cised, and the valves are lysed from below with a Mills 
valvulotome as antegrade distention is maintained 
from above by infusing Normasol solution (Abbott 
Laboratories, North Chicago, Ill.) with heparin 
(1000 U/500 ml) and papaverine (60 mg/500 ml). 
Alternatively, on the basis of the surgeon's preference 
(15% of cases), the proximal anastomosis may be 
completed after the graft is harvested and the valves 
are lysed with pulsatile arterial distention from above 
as in the INGSV bypass procedures. In cases in which 
vein graft sclerosis is present or intraluminal diseas.e 
such as web-like synechia is identified with the Mills 
valvulotome, an angioscope is passed through the ex 
situ vein graft to ensure that the conduit is satisfac- 
tory. 
Vein graft characteristics. The vein graft char- 
acteristics are shown in Table II. Forty-nine (26%) of 
the NRGSV bypass procedures were secondary oper- 
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Table II. Comparative characteristics of
NRGSV and INGSV 
NRGSV INGSV p 
Incidence of reopemtion 
PrimmTbypass 140 (74%) 521 (92%) <0.00l 
Secondary bypass 49 (26%) 47 (8%) <0.001 
Surgical indication 
Disabfingclaudicadon 21 (11%) 182 (32%) <0.001 
Limb salvage 168 (89%) 386 (68%) <0.001 
Restpain 64 (34%) I80 (32%) <0.56 
Ulcer 77 (41%) 143 (25%) <0.001 
Gangrene 27 (14%) 63 (11%) <0.24 
Inflow level 
Common femoral 91 (48%) 498 (88%) <0.001 
Superficial femoral 44 (23%) 58 (10%) <0.001 
Profunda femoral 2 (1%) 8 (1%) <0.72 
Popliteal 52 (28%) 4 (1%) <0.001 
Outflow level 
Popliteal 50 (27%) 282 (50%) <0.001 
Above-knee popliteal 16 (9%) 90 (16%) <0.01 
Below-knee poptiteal 34 (18%) 192 (34%) <0.001 
Tibial/pedal 139 (74%) 286 (50%) <0.001 
Tibioperoneal 3 (2%) 12 (2%) <0.65 
Anterior tibial 38 (20%) 73 (13%) <0.01 
Posterior tibial 34 (18%) 108 (19%) <0.76 
Peroneal 23 (12%) 76 (13%) <0.67 
Pedal 41 (22%) 17 (3%) <0.001 
ations that were performed after previous infraingui- 
nal graft failures, compared with only 47 secondary 
procedures (8%) among INGSV bypass operations 
(p < 0.001). Similarly, NRGSV bypass procedures 
were more commonly performed for limb salvage 
indications (89% limb salvage, 11% disabling claudi- 
cation) than were INGSV bypass procedures (68% 
limb salvage, 32 % dis abling claudication; p < 0.001 ). 
Ninety-eight percen t of INGSV bypass grafts arose 
from the common femoral (88%) or proximal super- 
tidal femoral artery (10%). Conversely, NRGSV by- 
pass grafts had more distal inflow sites, with 48% 
arising from the common femoral artery, 23% from 
the superficial femoral artery, and 28% form the pop- 
liteal artery (p < 0.001). Correspondingly, NRGSV 
grafts were completed to more distal outflow vessels 
(26% popliteal, 52% tibial, and 22% pedal arteries) 
than were iNGSV grafts (50% popliteal, 47% tibial, 
and 3% pedal arteries; p < 0,001). 
Database and statistical analysis. All patients in 
this study were prospectively entered into and fol- 
lowed-up in a UNiX-based computerized registry 
(Informix~SQL, Menlo Park, Calif.) that is main- 
tained by the vascular surgery division of Brigham 
and Women's Hospital. Categoric parameters were 
compared with the X 2 test, and continuous variables 
were compared with a two-sided Student's ttest, with 
a p value less than 0.05 considered statistically signif- 
icant. Standard errors for the life tables were calcu- 
Table III. Morbidity and mortality data 
NRGSV INGSV p 
Operative mortality rate* 2 (1%) 12 (2%) <0.20 
Major complication 10 (5%) 42 (7%) <0.32 
Myocardial infarction 2 (1%) 21 (4%) <0.67 
Stroke 1 (1%) 5 (1%) <0.64 
Renal failure 5 (3%) 12 (2%) <0.67 
Pulmonary 6 (3%) 11 (2%) <0.32 
30-day graft failure 11 (6%) 27(5%) <0.56 
30-day amputation rate 3 (2%) 5 (:1%) <0.41 
*Operative mortality rate = 30-day mortality rate. 
lated by the Greenwood method, with comparisons 
between the curves made by the Mantel-Cox log- 
rank test for significance. 6 
RESULTS 
Mortality and morbidity rates. The compara- 
tive morbidity and mortality rates for patients who 
underwent NRGSV or INGSV bypass procedures are 
shown in Table III There was a 1% 30-day mortality 
rate for patients who underwent NRGSV bypass, 
which did not differ significantly from the 2 1% mor- 
tality rate in INGSV patients (p < 0.20). The inci- 
dence of major complications was similar, occurring 
after 5.3% of NRGSV operations and 7.4% of the 
INGSV operaraons (p < 0.32). The 30-day graft 
failure rate was 5.8% for NRGSV and 4.8% for 
INGSV (p < 0.56). Similarly, the 30-day major am- 
putanon rates of 1.6% after NRGSV bypass and 0.9% 
after INGSV bypass did not differ significantly (p < 
0.41 ). Major wound complications (those that pro- 
longed hospitalization or required reoperation or 
readmission) occurred in 8% of INGSV arid 6% of 
NRGSV bypass patients. 
Graft patency, limb salvage, and survival rates. 
The patency and limb salvage rates for patients who 
underwent NRGSV or INGSV reconstruction are 
summarized in Fig. 1 and Table IV. The overall 
5-year primary patency rate for NRGSV grafts was 
65% ~- 5% and did not differ from the 72% --- 3% 
primary patency rate oflNGSV grafts (p < 0.12). The 
5-year secondary patency rates for INGSV grafts, at 
82% -- 2%, was higher than the 74% z 5% rate of 
NRGSV grafts, but this difference did not reach sta- 
tistical significance (p < 0.08). The 5-year survival 
rate of NRGSV patients (75% +_ 5%) did not differ 
from that of INGSV patients (71% + 3%; p < 0.23). 
Vein graft stenoses that required revision were de- 
tected by duplex scanning and occm'red in 7.2% of 
tNGSV and 5.8% of NRGSV bypass grafts. 
Among operations performed for limb salvage 
indications, NRGSV grafts and INGSV grafts dem- 
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Fig. 1. Primary and secondary patency rates for non-reversed greater saphenous vein grafts. 
Table IV. Graft patency and limb 
salvage rates 
Groups n 
5-year 5-year 5-year 
primary secondary limb 
patency patency salvage 
rate (%) rate (%) rate (%) 
Overall 
NRGSV 189 65 + 5 74-+5 84 _-24 
INGSV 521 72 +3 82±2 93-+ 1 
p <0.119 <0.082 <0.017 
Limb salvage operations 
NRGSV I68 66-+ 5 75-+5 82-+5 
INGSV 386 68 +3 80-+3 90±2 
p <0.334 <0.203 <0.062 
Claudication operations 
NRGSV 21 71 + 8 75 + 8 100% 
INGSV 182 79±4 86±3 98 + 1 
p <0.171 <0.261 <0.239 
Primary procedures 
NRGSV 140 65 +6 74±6 86 +4 
INGSV 521 73 +3 83 +2 94-±1 
p <0.119 <0.085 <0.045 
Secondary procedures 
NRGSV 49 66 + 8 77 + 7 83 + 6 
INGSV 47 70 + 8 75 + 8 87 + 6 
p <0.337 <0.433 <0.284 
Tibial/pedal bypass 
NRGSV 139 69±5 77 + 5 85 ±4 
INGSV 286 64-+4 75 ±4 90 +3 
p <0.248 <0.390 <0.113 
onstrated Similar patency rates. Five-year primary pa- 
tency rates for NRGSV grafts and INGSV grafts were 
66% + 5% and 68% - 3%, respectively (p < 0.33). 
Similarly, 5-year secondary patency rates were 75% + 
5% and 80% + 3% (p < 0.20). INGSV bypass proce- 
dures performed for limb salvage indications showed 
a trend toward superior 5-year limb salvage rates over 
NRGSV bypasses that did not attain statistical signif- 
icance (90% + 2% vs 82% + 5%; p < 0.06). 
NRGSVs and INGSVs performed equally well 
when operations were completed for disabling clau- 
dication. Five-year primary patency rates were 71% + 
8% and 79% + 4% for NRGSV and INGSV bypasses, 
respectively (p< 0.17). Secondary patency rates were 
75% _ 8% and 86% -+ 3% at 5 years (p < 0.26). Most 
importantly, surgeries that were performe d for dis- 
abling claudication were not associated with limb 
loss. The 5-year limb preservation rate was 100% in 
patients who had NRGSV bypasses and 99% + 1% 
after INGSV bypass procedures performed for clau- 
dication (p < 0.24). 
As shown in Table IV, the NRGSV bypass grafts 
performed as well as the INGSV bypass grafts 
whether the procedures were primary or secondary 
operations. Similarly, the results wer e comparable for 
the bypass grafts that extended to tibial and pedal 
outflow vessels. 
DISCUSSION 
Many vascular surgeons use the INGSV as their 
preferred autogenous conduit for performing infrain- 
guinal arterial reconstruction? -~ When the saphe- 
nous vein is removed from its bed, the reversed graft 
configuration has generally been the preferred tech- 
nique. 5 Our routine use of the in situ saphenous vein 
bypass technique and our comfort with valve lysis 
using the Mills valvulotome has led to a natural 
application of the NRGSV configuration i selected 
cases on our service. This technique was initially used 
only when saphenous vein excision was required, 
such as for use as a conduit in the contraiateral leg. 
Over time, however, we have become increasingly 
liberal about its use and allow the patient's anatomy 
to dictate the preferred operative approach. 
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We believe that the most important advantages of
the INGSV tecbmique are preserved when the 
NRGSV is used. Most saphenous veins have a signif- 
icant size taper, and the NRGSV configuration opti- 
mizes the size match between the artery and vein at 
the proximal and distal arterial anastomoses. We find 
that this match increases the precision of the anasto- 
mosis and maximizes the usage rate of the saphenous 
vein. Preservation of the proximal saphenous vein 
hood also facilitates the completion of the proximal 
anastomosis, especially when the anastomosis is per- 
formed to a large, thick-walled vessel. Inclusion of 
the saphenous vein hood at the proximal anastomosis 
has also virtually eliminated subsequent proximal vein 
graft stenosis, which remains an occasional problem 
with reversed saphenous vein grafts. 7,8 A previous 
study has suggested hemodynamic advantages and 
increased graft flow in nonreversed grafts with lysed 
Valves .9 These advantages should pertain equally well 
to NRGSVs and INGSVs. 
Obviously, there are several theoretic advantages 
to the INGSV technique that may not be preserved 
with the NRGSV configuration. Avoidance of warm 
ischemia time and improved preservation of the vas- 
cular endothelium with the INGSV graft may offer 
some short-term advantages, but seem to have little 
impact on long-term functional and morphologic 
graft characteristics.l°q2 Anothe r potential objection 
to using the NRGSV configuration for excised veins 
is that it requires unnecessary intraluminal manipula- 
tion of the vein for valve lysis that would not be 
required with a reversed saphenous vein. In fact, we 
do not hesitate to use the reversed saphenous vein 
configuration when there is no significant taper (or a 
reversed taper) in an excised saphenous vein. Numer- 
ous reports oflNGSV bypass procedures inwhich the 
modified Mills valvulotome was used have demon- 
st_rated, however, that in experienced hands, it is a safe 
and effective instrument for valve lysis. >4 We have 
found that passage of the Mills valvulotome allows a 
tactile assessment of the intraluminal qualifies of the 
vein graft and often allows us to identify unsuspected 
areas of sclerosis or synechiae. This finding has 
prompted angioscopi c examination and revision of 
the conduit on a number of occasions. 
We believe that the NRGSV graft configuration 
offers advantages over the INGSV graft configuration 
in selected cases. When shorter bypass grafts are based 
on more distal inflow vessels, the saphenous vein 
from the thigh, including the proximal vein hood 
(which is often the best-quality vein segment), may 
be transposed to the optimal position. Similarly, 
when the patient's vascular anatomy calls for subcu- 
taneous tunneling along the lateral thigh or along 
deep anatomic planes, the NRGSV graft offers an 
ideal configuration. Finally, when bypass grafts to the 
pedal arteries are required, transposition ofa NRGSV 
graft avoids the parallel distal anlde and foot incisions 
that are required when preparing an INGSV graft of 
sufficient length. Occasionally these parallel wounds 
create postoperative problems as the foot swells. 
It is not the intention of this review to demon- 
strate the superiority of the NRGSV bypass graft to 
the INGSV bypass graft. The INGSV remains the 
most common graft configuration for primary bypass 
grafts on our service. We have previously reported 
INGSV bypass 10-year primary and secondary pa- 
tency rates of 60% and 76%, respectively, with limb 
salvage rates of 90% over the same interval, aNearly 
identical 10-year esults were recently reported by 
Shah and associates I after more than 2000 INGSV 
bypass operations. Thus the INGSV conduit remains 
the benchmark against which other conduits must be 
compared. We therefore were encouraged to find in 
this review that the NRGSV configuration performed 
as well as our concurrent series of INGSVs after 5 
years of follow-up. This is particnlarly remarkable 
because the NRGSV bypasses in this series consti- 
tuted a more challenging roup than the INGSV 
bypasses. The NRGSV bypasses used significantly 
more distal inflow and outflow vessels, were more 
commonly performed for limb salvage indications, 
and were more often secondary procedures than were 
INGSV bypasses. The increased incidence of limb 
salvage and secondary bypasses, inparticular, places this 
group at risk for lower patency and limb salvage rates. 13 
The vascular surgery literature contains relatively 
few reports that focus on the NRGSV as a conduit for 
infrainguinal arterial reconstruction} 2,1<is Most of 
these reports contain small numbers of patients 
(< 50 ) who were observed for limited intervals (<2 
years). Undoubtedly, many vascular surgeons who 
routinely prefer the INGSV configuration use the 
NRGSV on an occasional, selective basis. Similarly, 
many NRGSV bypass procedures are buried within 
larger series of infralnguinal arterial reconstruction 
Pomposelli et al., 16 for example, recently reported on 
384 bypass procedures to the dorsalis pedis artery, 
which included 68 NRGSV bypass procedures. The 
patency rates of all translocated saphenous vein grafts 
in that series (including both NRGSV and reversed 
grafts) did not differ from those of INGSVs. 
CONCLUSION 
NRGSV is a useful and durable conduit for in- 
fraingu_inal arterial reconstruction that preserves the 
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major advantages of the INGSV bypass configura- 
tion. On the basis of the patient's pathologic anatomy 
and saphenous vein availability, selective application 
of the NRGSV may offer advantages and may be used 
with the expectation ofpatency and limb salvage rates 
similar to those achieved with the INGSV. 
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